PT-141 user experiences: what users themselves report

Users’ own accounts, not research. The accounts are self-selected and prove neither that it works nor that it is safe.

This page does not list users’ doses or sellers, and no figure on it is a recommendation. Doses used in studies, with sources: PT-141 dosage in studies.

In short

Of 59 people, 35 (59%) said PT-141 brought some benefit and 43 (73%) some harm.

Where the accounts come from and how we read them

Sources: the Reddit forums r/Peptides (40 accounts), r/Biohackers (13), r/Melanotan2 (7), r/Nootropics (1) and r/Retatrutide (1), 22 Oct 2024 to 4 Oct 2026. The posts were retrieved from a public Reddit archive. From first-person posts about PT-141, 198 were picked at random, and every one was read.

Coding: for each account we recorded the route, reported benefits and harms, how strong a harm was, whether and why the person stopped, length of use and other substances used at the same time. We kept accounts that reported some effect, some harm, or no effect. Questions and plans were left out. A harm was recorded when the person reported it during use, even if the cause was uncertain. Several posts by one person count as one person. One person can mention several things, so the shares in the tables do not add up to 100.

Check: an AI model read and classified the posts following written instructions. A second, separate AI run classified a random tenth (20 posts) again without seeing the first classification. The main fields matched: 18/20 (90%).

Whose accounts these are: routes mentioned: injection 20, nasal spray 3; the others did not say. The figures describe the writers and are not a recommendation. The products were not verified, so we do not know what people actually took.

Did PT-141 help? The overall picture

Of 59 people, 12 (20%) reported benefit only, 23 (39%) both benefit and harm, 20 (34%) harm only and 4 (7%) neither.

Stopping. 4 people (7%) said they stopped or paused: 4 because of harms and 0 because they noticed no effect or for another reason.

Share = people / 59.
Overall picture: benefit, harm or neitherPeopleShare
Benefit only1220%
Both benefit and harm2339%
Harm only2034%
Neither benefit nor harm47%

Most common reported benefits

Of 59 people. 35 (59%) mentioned some benefit; the table lists every benefit reported.

ReportedPeopleShare
Better erections1729%
More sexual desire1119%
Arousal or orgasm915%
Other benefit1525%

Share = people / 59.

Most common reported harms

Of 59 people. 43 (73%) mentioned some harm; 2 said explicitly they had none.

ReportedPeopleShare
Flushing1729%
Nausea or vomiting1424%
Fatigue610%
Stomach upset (other than nausea)58%
Headache58%
Heart or blood pressure35%
Injection-site reaction35%
Prolonged erection35%
Skin darkening or mole changes35%
Other, rarer harm2034%
Harms mentioned but not named23%

Share = people / 59.

How severe were the harms?

Of the 42 people who described how strong a harm was, 22 (52%) described it as mild, 19 (45%) as clearly bothersome and 1 (2%) as severe. The strength is the writer's own description, not a doctor's assessment.

Share = people / 42.
Strength of the harm as the writer described itPeopleShare
Mild: minor and manageable2252%
Clearly bothersome: several days, sleep or work affected1945%
Severe: emergency visit, hospital or unable to function12%

Harms known from research and regulators: What are the side effects of PT-141?

How long did people use PT-141?

34 of 59 people (58%) said how long they had been using it at the time of writing. Where one person wrote several posts, the longest stated time counts.

Share = people / 34.
Stated length of usePeopleShare
Under a week3088%
1-4 weeks26%
1-3 months00%
Over 3 months26%

Many people post partway through, often in the first days or as soon as harms start, so short times are over-represented. The numbers describe the writers; they do not say how long it should be used.

Other substances at the same time

21 of 59 people (36%) used other substances at the same time. The most common: melanotan II (6), retatrutide (6), GHK-Cu (3), SS-31 (3), tadalafil (3) and one more equally common. Then the account cannot tell which substance had the effect.

About dosing

We do not repeat the amounts or ways of use people mention, and we give no dosing or how-to instructions. A safe dose is not known. Doses used in studies, with sources: PT-141 dosage in studies and in the label. Legal status: Is PT-141 legal in Finland?

What can be concluded?

The reported benefits were about erections, desire and arousal, and the most common harms were flushing and nausea. Use was mostly one-off, so the accounts say nothing about long-term effects.

The accounts prove neither that it works nor that it is safe. The writers are self-selected, the product contents are unknown, many used several substances at once, and placebo effects can be large. The research and its evidence levels: PT-141: what the research shows.

Quotes

Short excerpts in the writers’ own words. Writers’ names and links are not shown. We picked quotes from every group: benefit, both benefit and harm, no effect, harms and people who stopped.

Other summaries made with the same method: BPC-157 user experiences, Melanotan II user experiences, Retatrutide user experiences, GHK-Cu user experiences, NAD+ user experiences, TB-500 user experiences, Semax user experiences and user experiences with collagen and skin peptides.

Content is general information about research, not medical advice. If you have symptoms, contact a healthcare professional.